BRIEF published on 06/25/2024 at 19:04, 4 months 27 days ago Molten Ventures Plc: Notice of Major Shareholding by BlackRock, Inc. Voting Rights BlackRock Financial Instruments Molten Ventures Shareholder
PRESS RELEASE published on 06/25/2024 at 18:59, 4 months 27 days ago Molten Ventures Plc: HOL-Holding(s) in Company Molten Ventures Plc (GROW; GRW) reports holding(s) notification by BlackRock, Inc. acquiring voting rights on 24-Jun-2024 Voting Rights Molten Ventures Plc GROW GRW BlackRock Inc.
BRIEF published on 06/24/2024 at 19:00, 4 months 28 days ago Molten Ventures Plc: Grant of Share Options to Key Personnel PDMR Molten Ventures LTIP Grant Of Options DBP
PRESS RELEASE published on 06/24/2024 at 18:55, 4 months 28 days ago Molten Ventures Plc: DSH-Director/PDMR Shareholding Molten Ventures Plc announces the award of options over ordinary shares to certain PDMRs under LTIP and DBP, as detailed in the press release Molten Ventures Plc LTIP PDMRs DBP Options Award
BRIEF published on 06/12/2024 at 19:00, 5 months 10 days ago Molten Ventures Plc Announces Major Holding Notification by BlackRock, Inc. Voting Rights Molten Ventures Plc Major Holdings Finance BlackRock Inc.
PRESS RELEASE published on 06/12/2024 at 18:55, 5 months 10 days ago Molten Ventures Plc: HOL-Holding(s) in Company* Molten Ventures Plc (GROW; GRW) announces notification of major holdings by BlackRock, Inc. on 11-Jun-2024 Molten Ventures Plc Major Holdings GROW GRW BlackRock Inc.
BRIEF published on 06/12/2024 at 14:35, 5 months 10 days ago Molten Ventures Plc Announces 2024 AGM Notice Shareholders Investors Financial Announcement Molten Ventures AGM Notice
PRESS RELEASE published on 06/12/2024 at 14:30, 5 months 10 days ago Molten Ventures Plc: NOA-Notice of AGM Molten Ventures Plc announces the Notice of 2024 Annual General Meeting (AGM) with details on shareholders' attendance and access to documentation Shareholders Molten Ventures Plc AGM Meeting Public Market Investors
BRIEF published on 06/12/2024 at 08:05, 5 months 10 days ago Molten Ventures Reports Final Results for Year Ending March 2024 Acquisition Financial Results ESG Venture Capital Molten Ventures
PRESS RELEASE published on 06/12/2024 at 08:00, 5 months 10 days ago Final Results Molten Ventures Plc announces final results for the year ended 31 March 2024, reporting a £1,379m Gross Portfolio Value and successful investments in high-growth tech companies Molten Ventures Plc GROW GRW Technology Investments Final Results
Published on 11/22/2024 at 18:45, 25 minutes ago CORRECTING and REPLACING the Not-So-Secret Lives of REAL "Mormon" Wives - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/22/2024 at 16:00, 3 hours 10 minutes ago Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 3 hours 15 minutes ago Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 3 hours 55 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 4 hours 25 minutes ago Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 18:14, 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 hour 17 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 2 hours 15 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 3 hours 10 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 12 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 23 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 1 hour ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 1 hour ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
